Akebia Therapeutics, Inc. Financial Ratios — AKBA Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-71.35	-50.85	-47.82	-61.26	-22.17	-21.1	-31.64	-54.38	-48.07	-21.28	-17.37	-30.02	-1.79
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	100	100	96.26	56.62	-0.62	28.81	70.74	61.9	60.56	83.29
EBITDA Margin (%)	- -	- -	- -	- -	-8,870.62	-41.97	-84.6	-73.92	-116.46	-107.03	-9.28	-4.34	-8.06	10.49
Operating Margin (%)	- -	- -	- -	- -	-8,889.9	-42.31	-85.76	-85.46	-128.23	-124.97	-22.17	-23.67	-31.47	9.95
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	97.23
Pretax Margin (%)	- -	- -	- -	- -	-8,843.45	-40.65	-82.76	-85.46	-130.61	-133.25	-32.22	-26.68	-43.33	-1.58
Profit Margin (%)	- -	- -	- -	- -	-8,843.45	-40.65	-69.12	-83.48	-130.61	-133.25	-32.22	-26.68	-43.33	-2.26
Net Income to Common Margin (%)	- -	- -	- -	- -	-8,843.45	-40.65	-69.12	-83.48	-130.61	-133.25	-32.22	-26.68	-43.33	-2.26
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	15	108	126	136	100	48	48	52
ST Debt	- -	- -	- -	- -	- -	- -	15	5	5	102	37	22	5	4
LT Debt	- -	- -	- -	- -	- -	- -	- -	103	121	34	63	26	42	48
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	-0.09	-0.44	-0.37	-0.6	-3.68	-5.7	-3.69	2.09
Net Debt/EBITDA	0.19	1.33	0.87	0.81	1.38	0.92	0.51	0.29	0.39	0.23	0.9	0.98	1.02	-5.51
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	-0.08	-0.38	-0.33	-0.51	-1.54	-1.04	-0.94	2.2
Net Debt/EBIT	0.19	1.33	0.86	0.81	1.37	0.91	0.5	0.25	0.35	0.2	0.38	0.18	0.26	-5.81
EBITDA to Interest Expense	- -	-22.64	- -	- -	- -	- -	- -	- -	-38.68	-11.36	-1.73	-1.4	-0.71	1.02
EBITDA-CapEx/Interest Expense	- -	-22.67	- -	- -	- -	- -	- -	- -	-38.72	-11.37	-1.74	-1.4	-0.71	0.69
EBIT to Interest Expense	- -	-22.65	- -	- -	- -	- -	- -	- -	-42.59	-13.27	-4.13	-7.64	-2.77	0.97
Interest Expense	- -	1	- -	- -	- -	- -	- -	- -	9	20	16	6	18	24
Common Equity/Total Assets	-2,655.59	-366.57	-90.7	-112.91	-98.97	-101.8	-51.62	-102.96	-182.8	-276.34	-437.3	-665.67	-760.57	-447.12
Long-Term Debt/Equity (%)	- -	0.03	- -	- -	- -	- -	- -	26.18	48.87	45.54	1,205.33	- -	- -	147.96
Long-Term Debt/Capital (%)	- -	0.03	- -	- -	- -	- -	- -	-15.07	-11.51	-2.54	-4.33	-1.67	-2.59	-2.96
Long-Term Debt/Total Assets (%)	- -	0.02	- -	- -	- -	- -	- -	13.4	18.78	6.37	17.7	10.81	19.14	12.81
Total Debt/Equity (%)	- -	0.04	- -	- -	- -	- -	2.36	27.44	51	183.83	1,907.9	-157.34	-96.86	158.84
Total Debt/Capital (%)	- -	0.04	- -	- -	- -	- -	-3	-15.8	-12.01	-10.25	-6.85	-3.08	-2.92	-3.17
Total Debt/Total Assets (%)	- -	0.03	- -	- -	- -	- -	1.51	14.05	19.61	25.7	28.02	19.91	21.59	13.76
Net Debt to Equity	61.25	-68.98	-31.5	-38	-275.01	-57.24	-14.1	-18.15	-53.44	-70.61	-466.31	26.95	26.79	-418.87
Net Debt/Capital (%)	37.98	-222.1	24.56	23.57	38.67	15.91	14.84	8.6	10.34	3.54	1.58	0.51	0.78	7.52
EBITDA	-9	-16	-38	-61	-136	-76	-176	-248	-343	-227	-27	-8	-13	25
EBITDA-CapEx	-9	-16	-38	-62	-139	-78	-177	-254	-343	-227	-27	-8	-13	17
Operating Income (Loss)	-9	-16	-38	-62	-136	-77	-178	-286	-378	-265	-65	-46	-50	23

Liquidity (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.33	8.34	15.82	11.67	2.28	2.25	1.21	0.71	1.44	0.57	0.7	0.43	0.64	1.13
Current Ratio	0.46	8.57	16.05	11.88	2.59	2.54	1.76	1.49	1.98	1.04	1.43	1.18	1.41	1.55
Quick Ratio	0.35	8.38	15.83	11.67	2.57	2.49	1.27	0.9	1.58	0.77	1.01	0.82	1.07	1.42
CFO/Avg Current Liab	- -	-2.57	-5.1	-5.59	0.92	-0.44	-0.48	-1.09	-0.56	-1.13	-0.37	-0.2	-0.45	0.56
Common Equity/Total Assets	-2,655.59	-366.57	-90.7	-112.91	-98.97	-101.8	-51.62	-102.96	-182.8	-276.34	-437.3	-665.67	-760.57	-447.12
Long-Term Debt/Equity (%)	- -	0.03	- -	- -	- -	- -	- -	26.18	48.87	45.54	1,205.33	- -	- -	147.96
Long-Term Debt/Capital (%)	- -	0.03	- -	- -	- -	- -	- -	-15.07	-11.51	-2.54	-4.33	-1.67	-2.59	-2.96
Long-Term Debt/Total Assets (%)	- -	0.02	- -	- -	- -	- -	- -	13.4	18.78	6.37	17.7	10.81	19.14	12.81
Total Debt/Equity (%)	- -	0.04	- -	- -	- -	- -	2.36	27.44	51	183.83	1,907.9	-157.34	-96.86	158.84
Total Debt/Capital (%)	- -	0.04	- -	- -	- -	- -	-3	-15.8	-12.01	-10.25	-6.85	-3.08	-2.92	-3.17
Total Debt/Total Assets (%)	- -	0.03	- -	- -	- -	- -	1.51	14.05	19.61	25.7	28.02	19.91	21.59	13.76
CFO/Total Liabilities	-146.47	-289.82	-397.33	-438.85	24.95	-23.24	-27.04	-68.39	-27.84	-55.56	-20.85	-8.59	-15.07	19.77
CFO/CapEx	- -	-596.42	-120.01	-126.59	21.75	-34.62	-60.71	-38.68	-348.23	-4,287.54	-641.7	- -	-1,232.09	8.4
Altman's Z-Score	-51.15	-5.63	14.28	15.27	-1.14	0.7	-0.32	-2.57	-4.76	-6.95	-8.87	-14.41	-13.44	-5.37

Working Capital (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	0.09	5.33	8.17	12.07	8.97	5.4	6.37	4.89	4.35	5.8
Days Sales Outstanding	- -	- -	- -	- -	4,021.3	68.52	44.7	30.25	40.7	67.63	57.32	74.62	83.92	62.89
Inventory Turnover	- -	- -	- -	- -	- -	- -	0.14	1.26	3.34	3.09	2.94	3.98	3.96	2.48
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	2,684.05	289.56	109.18	118.27	124.12	91.7	92.25	147.31
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	4.9	3.6	5.99	3.37	2.73	4.18	4.27	2.14
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	74.48	101.52	60.94	108.24	133.58	87.29	85.38	170.92
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	2,654.27	218.3	88.94	77.67	47.86	79.03	90.79	39.29
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	-2,639.35	-259.31	-68.48	-50.64	-66.8	-17.09	-8.33	-84.42
Inventories	- -	- -	- -	- -	- -	- -	114	116	61	37	22	16	16	16
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8	4	12	13
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14	11	4	3
Other Inventory	- -	- -	- -	- -	- -	- -	114	116	61	37	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	179	342	393	647	646	748	388	375	105	232	401	414
- Cash & Cash Equivalents	2	21	33	50	187	70	105	147	229	150	90	43	52	185
+ Preferred Equity and Hybrid Capital	57	158	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	15	108	126	136	100	48	48	52
Enterprise Value	55	125	70	204	132	329	340	709	245	361	115	238	397	281
Total Capital	-3	31	-101	-161	-297	-371	-499	-686	-1,051	-1,327	-1,457	-1,561	-1,631	-1,632
Total Debt/Capital (%)	- -	0.04	- -	- -	- -	- -	-3	-15.8	-12.01	-10.25	-6.85	-3.08	-2.92	-3.17
Total Debt / EV	- -	- -	- -	- -	- -	- -	0.04	0.15	0.51	0.38	0.87	0.2	0.12	0.18
EV/Sales	- -	- -	- -	- -	86.18	1.82	1.64	2.12	0.83	1.71	0.39	1.22	2.48	1.19
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.34
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.96
EV/Cash Flow to Firm	- -	- -	- -	- -	2.28	- -	- -	- -	- -	- -	- -	- -	- -	2.74
EV/Free Cash Flow to Firm	- -	- -	- -	- -	2.18	- -	- -	- -	- -	- -	- -	- -	- -	2.54
Diluted Market Cap	- -	- -	179	342	393	647	646	748	388	375	105	232	401	414
Diluted Enterprise Value	55	137	147	292	205	577	557	709	285	361	115	238	397	281
EV per Share	5.45	6.5	4.57	7.69	3.51	7.56	2.91	5.99	1.77	2.18	0.63	1.27	1.88	1.09
TTM Sales	- -	- -	- -	- -	2	181	208	335	295	212	292	195	160	236
TTM EBITDA	-9	-16	-38	-61	-136	-76	-176	-248	-343	-227	-27	-8	-13	25
TTM Operating Income	-9	-16	-38	-62	-136	-77	-178	-286	-378	-265	-65	-46	-50	23
TTM Cash Flow to Firm	-7	-11	-27	-52	58	-56	-97	-257	-102	-233	-57	-17	-22	103
TTM Free Cash Flow to Firm	-7	-11	-27	-52	61	-55	-96	-251	-101	-233	-57	-17	-22	111

Multiples (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-6.58	-6.58	6.48	-11.86	-6.74	-2.98	-3.52	-1.48	-1.44	-9.94	-9.87	5.44
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.96
Enterprise Value	55	125	70	204	132	329	340	709	245	361	115	238	397	281
Low Price	- -	- -	8.6	5.91	7	8.58	5.2	2.99	2.09	2.2	0.24	0.49	0.8	1.45
EV/Sales	- -	- -	- -	- -	86.18	1.82	1.64	2.12	0.83	1.71	0.39	1.22	2.48	1.19
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.34
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-8.51	-4.2	-2.36	-8.04	-8.27	-2.28	-2.68	-1.84	-1.57	-3.64	-4.49	-123.11
Price/Earnings High	- -	- -	-12.9	-6.19	-3.54	-11.96	-12.91	-3.94	-4.93	-3.02	-5.68	-6.64	-7.54	-196.3
Price/Earnings Low	- -	- -	-3.58	-2.58	-1.94	-5.07	-4.23	-1.27	-0.75	-1.29	-0.47	-1.77	-2.43	-69.76
Price/Book Value	- -	- -	-1.78	-2.12	-1.32	-1.74	-1.26	-0.94	-0.33	-0.26	-0.07	-0.14	-0.24	-0.25
Price/Book Value Average	- -	- -	-3.13	-1.58	-1.08	-1.6	-2.31	-0.8	-0.88	-0.36	-0.1	-0.12	-0.19	-0.39
Price/Book Value High	- -	- -	-4.74	-2.33	-1.62	-2.38	-3.6	-1.39	-1.61	-0.58	-0.34	-0.21	-0.31	-0.62
Price/Book Value Low	- -	- -	-1.32	-0.97	-0.89	-1.01	-1.18	-0.45	-0.25	-0.25	-0.03	-0.06	-0.1	-0.22
Price/Tangible Book Value	- -	- -	1.72	2.61	5.76	5.28	2.56	15.43	8.01	-4.03	-0.84	-1.85	-3.7	-15.66
Price/Tangible Book Value Average	- -	- -	3.03	1.95	4.7	4.83	4.7	13.13	21.29	-5.58	-1.18	-1.51	-2.88	-24.89
Price/Tangible Book Value High	- -	- -	4.59	2.87	7.05	7.19	7.34	22.71	39.23	-9.16	-4.25	-2.74	-4.83	-39.69
Price/Tangible Book Value Low	- -	- -	1.27	1.19	3.88	3.04	2.41	7.3	5.98	-3.92	-0.35	-0.73	-1.56	-14.11
Price/Sales	- -	- -	- -	- -	255.79	3.57	3.11	2.23	1.32	1.77	0.36	1.19	2.5	1.75
Price/Sales Average	- -	- -	- -	- -	208.64	3.27	5.72	1.9	3.5	2.45	0.51	0.97	1.94	2.79
Price/Sales High	- -	- -	- -	- -	313.04	4.86	8.92	3.29	6.44	4.03	1.83	1.77	3.27	4.44
Price/Sales Low	- -	- -	- -	- -	172	2.06	2.93	1.06	0.98	1.72	0.15	0.47	1.05	1.58
Price/Cash Flow	- -	- -	-6.53	-6.53	6.78	-11.52	-6.63	-2.91	-3.51	-1.48	-1.44	-9.94	-9.86	6.09
Price/Cash Flow Average	- -	- -	-11.47	-4.86	5.53	-10.55	-12.18	-2.47	-9.33	-2.05	-2.03	-8.09	-7.66	9.68
Price/Cash Flow High	- -	- -	-17.38	-7.17	8.3	-15.69	-19.01	-4.28	-17.2	-3.37	-7.32	-14.75	-12.87	15.43
Price/Cash Flow Low	- -	- -	-4.82	-2.98	4.56	-6.65	-6.23	-1.38	-2.62	-1.44	-0.6	-3.93	-4.15	5.48
Price/Free Cash Flow Average	- -	- -	-11.57	-4.9	5.29	-10.86	-12.39	-2.54	-9.36	-2.05	-2.03	-8.09	-7.66	8.65
Price/Free Cash Flow High	- -	- -	-17.52	-7.23	7.93	-16.15	-19.33	-4.39	-17.25	-3.37	-7.33	-14.75	-12.88	13.79
Price/Free Cash Flow Low	- -	- -	-4.86	-3.01	4.36	-6.84	-6.34	-1.41	-2.63	-1.44	-0.6	-3.93	-4.15	4.9
EV/Sales Average	- -	- -	- -	- -	86.6	2.88	5.29	1.78	3.15	2.39	0.54	1	1.92	2.22
EV/Sales High	- -	- -	- -	- -	191	4.47	8.49	3.17	6.1	3.97	1.86	1.8	3.24	3.88
EV/Sales Low	- -	- -	- -	- -	49.96	1.67	2.49	0.94	0.63	1.66	0.18	0.5	1.03	1.02
EV/EBITDA Average	-6.48	-8.58	-7.46	-3.34	-0.98	-6.86	-6.25	-2.41	-2.7	-2.23	-5.8	-23.02	-23.79	21.2
EV/EBITDA High	-6.48	-8.58	-11.74	-5.31	-2.15	-10.66	-10.04	-4.29	-5.23	-3.7	-20.07	-41.45	-40.2	36.99
EV/EBITDA Low	-6.48	-8.58	-2.63	-1.74	-0.56	-3.98	-2.95	-1.27	-0.54	-1.55	-1.97	-11.49	-12.74	9.68
EV/EBIT Average	-6.48	-8.57	-7.45	-3.34	-0.97	-6.81	-6.16	-2.09	-2.46	-1.91	-2.43	-4.22	-6.09	22.34
EV/EBIT High	-6.48	-8.57	-11.72	-5.3	-2.15	-10.57	-9.9	-3.71	-4.75	-3.17	-8.4	-7.6	-10.29	38.99
EV/EBIT Low	-6.48	-8.57	-2.63	-1.73	-0.56	-3.95	-2.91	-1.1	-0.49	-1.33	-0.82	-2.11	-3.26	10.21
Last Price	- -	- -	11.64	12.92	10.41	14.87	5.53	6.32	2.8	2.26	0.58	1.24	1.9	1.61
High Price	- -	- -	31	14.2	12.74	20.25	15.86	9.3	13.71	5.14	2.93	1.84	2.48	4.08
Enterprise Value Average	55	137	283	205	133	522	1,098	598	928	506	158	194	307	525
Enterprise Value High	55	137	445	326	293	811	1,764	1,062	1,796	839	545	350	519	916
Enterprise Value Low	55	137	100	107	77	303	518	315	187	351	53	97	165	240

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	19	20	20	31	39	48	117	122	148	177	184	195	225	265
Diluted Weighted Avg Shares	10	19	15	26	38	44	117	118	138	166	183	187	211	257
Basic Weighted Avg Shares	10	19	15	26	38	44	117	118	138	166	183	187	211	257
Revenue per Share	- -	- -	- -	- -	0.04	4.17	1.78	2.83	2.13	1.28	1.6	1.04	0.76	0.92
EBITDA per Share	-0.84	-0.83	-2.46	-2.32	-3.61	-1.75	-1.5	-2.09	-2.48	-1.37	-0.15	-0.05	-0.06	0.1
Operating Income per Share	-0.84	-0.83	-2.46	-2.32	-3.62	-1.76	-1.52	-2.42	-2.73	-1.59	-0.35	-0.25	-0.24	0.09
Basic EPS, GAAP	-0.81	-0.68	-2.4	-2.29	-3.6	-1.69	-1.23	-2.36	-2.78	-1.7	-0.52	-0.28	-0.33	-0.02
Basic EPS from Cont Ops	-0.81	-0.68	-2.4	-2.29	-3.6	-1.69	-1.23	-2.36	-2.78	-1.7	-0.52	-0.28	-0.33	-0.02
Diluted EPS, GAAP	-0.81	-0.68	-2.4	-2.29	-3.6	-1.69	-1.23	-2.36	-2.78	-1.7	-0.52	-0.28	-0.33	-0.02
Diluted EPS from Cont Ops	-0.81	-0.68	-2.4	-2.29	-3.6	-1.69	-1.23	-2.36	-2.78	-1.7	-0.52	-0.28	-0.33	-0.02
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.71	-0.59	-1.78	-1.98	1.54	-1.29	-0.83	-2.17	-0.8	-1.52	-0.4	-0.12	-0.19	0.26
Free Cash Flow per Basic Share	-0.71	-0.59	-1.8	-2	1.46	-1.33	-0.85	-2.23	-0.8	-1.52	-0.4	-0.12	-0.19	0.23
Cash & Equivalents per Share	0.16	1.69	7.07	5.23	6.9	7.31	2.75	1.25	1.94	0.9	0.49	0.23	0.25	0.72
Book Value per Share	-5.88	-6.59	-6.53	-6.1	-7.88	-8.52	-4.4	-6.71	-8.5	-8.81	-8.52	-8.58	-7.96	-6.55
Tangible Book Value per Share	-5.88	-6.59	6.76	4.95	1.81	2.82	2.16	0.41	0.35	-0.56	-0.69	-0.67	-0.51	-0.1

Akebia Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)